Health knowledge made personal
Home
Communities
WellPages
Resources Near You
WellTools
My Wellsphere
Sign Up!
•
Log in
Irv Arons
Top HealthBlogger
for the
General Medicine Community
Peabody, Massachusetts
Blog:
http://irvaronsjournal.blogspot.com/
I am now retired after spending the last 30 years consulting in ophthalmic and medical lasers and...
Full Bio
Summary
Goals
Posts
Friends
More
Bio
Bookmarks
Communities
Latest Activity
Teams
Whiteboard
Add to my friends
Send a message
+ Bookmark page
› Share page:
Posts
Sort by:
Most recent
|
Name
1-20
prev
1
2
3
4
next
The First Ophthalmic Innovation Summit
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
Earlier this year, two venture capitalists, Emmett Cunningham of Clarus Ventures and Bill Link of Versant Ventures, came up with the idea to hold a meeting prior to this year’ ...
Read on »
Avastin/Lucentis Update 35: The CMS Does the Full Monty on Code Q2024 for Avastin!
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
According to an email received yesterday by Jack Mitchell of the Senate Committee on Aging, “Effective immediately, CMS is no longer going to recognize code Q2024 for payment ...
Read on »
Oraya IRay In-office Stereotactic X-ray Treatment for AMD: A First Report
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
Another new company with a treatment for wet AMD has come out of “stealth mode”, and presented information on how it’s system works and the results of it’s initial clinical tr ...
Read on »
Avastin/Lucentis Update 34: More on the Comparative Studies
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
In my constant search for new information about AMD treatments, I happened across a blog devoted to all things retina: The Retina Blog. In one posting, following the recent AA ...
Read on »
Avastin/Lucentis Update 33: The Wording of the CMS Order for Repricing of Avastin
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
The following note was received this morning by my contact in Senator Kohl’s office, from the director of CMS’ Office of Legislation, along with the wording, shown below, take ...
Read on »
Menu – Part 14: Some Updates and a Few New Posts
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
Since the last menu posting on June 12th, I have added two new updates on the CATT Study; eight updates on Avastin vs. Lucentis; and three new postings. The new postings inclu ...
Read on »
Avastin/Lucentis Update 32: More on the CMS Repricing of Avastin
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
During the 2009 AAO Meeting in San Francisco, there was much discussion of the CMS cuts in reimbursement of Avastin beginning at the beginning of October.Crystal Phend of MedP ...
Read on »
Avastin/Lucentis Update 31: Problems with Pharmacy Compounding of Avastin?
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
A disturbing report from the 2009 AAO Meeting, as described on the OSN Supersite. Dr. Malik Kahook, speaking at the joint meeting, said that he had seen 16 cases of IOP spikes ...
Read on »
CATT Study Update 10 – From the 2009 AAO Meeting
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
According to Dr. J. Kitchens, Tweeting from the Retina SubSpecialty Day Session at the 2009 AAO Meeting, Dan Martin, head of the CATT Study, reported this morning that the stu ...
Read on »
Avastin/Lucentis Update 30: A Followup to Update 26 – Sen. Herb Kohl Queries CMS
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
As reported by Alicia Mundy in a Wall Street Journal Health Blog yesterday evening, Senator Herb Kohl wants to know if Genentech had any input into the CMS decision to reduce ...
Read on »
Avastin/Lucentis Update 29: Six-Month Results of Controlled Comparison Study Published
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
Apparently, Boston University School of Medicine and the VA Boston, have published the first six-month results of a comparison study of Lucentis vs. Avastin, and found no diff ...
Read on »
Avastin/Lucentis Update 28: Sustained Release Lucentis May Eventually Change the Equation
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
In an announcement this morning, Roche and Genentech announced that they had struck a licensing and development deal with Surmodics, Inc., for the latter’s proprietary, biode ...
Read on »
Avastin/Lucentis Update 27: Dr. Rosenfeld’s Remarks at Retina Congress 2009
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
The following abstract of Dr. Rosenfeld’s remarks were reported by OSN Supersite in their continuing coverage of Retina Congress 2009.Search for optimal anti-VEGF dosing strat ...
Read on »
Avastin/Lucentis Update 26: CMS Ups the Ante
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
A few days ago, Dr. Philip Rosenfeld told me that Medicare was slashing the reimbursement for Avastin to $7.20 a dose, an unintended consequence of their new Avastin code for ...
Read on »
Endoscopy in Ophthalmology: The Latest News and Some History
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
I saw a brief writeup in the current OSN Supersite (September 22, 2009) about Endo Optiks launching a new series of high-resolution micro-endoscopes and it brought to mind the ...
Read on »
Avastin/Lucentis Update 25: Comparative Studies Proliferate – France Joins the Fray
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
According to a story just published in APM Health Europe (September 14, 2009), a French study comparing Roche's Avastin (bevacizumab) and Novartis' Lucentis (ranibizumab) in t ...
Read on »
A Review of the History of Customized Corneal Ablation (Custom LASIK)
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
With the recent announcement by Technolas Perfect Vision of the FDA approval of its iris-tracking laser to improve LASIK outcomes, it reminded me that I was among the first to ...
Read on »
CATT Study Update 9: The CATT Study is On Track
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
I first learned of the possibility of there being a comparative study of Avastin vs. Lucentis in June 2007. I then followed its progress until it finally became a reality in F ...
Read on »
Femtosecond Lasers Proposed for Use in Cataract Surgery
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
As readers of this Journal know, I’ve been actively following developments in the use of femtosecond (FS) lasers. An old friend of mine, Larry Haimovitch, who contributes to B ...
Read on »
Menu – Part 13: A Few Updates and Some New Posts
by
Irv Arons
Posted in:
Blog Posts
in
General Medicine
Since the last menu posting, I have added two updates for AMD; a new approach for treating myopia with femtosecond lasers; a list of my private client studies while at Arthur ...
Read on »
1-20
prev
1
2
3
4
next
Related Articles
How smart patients keep fit ! An Expert Patient's first person account
We Have A Star
Pre Tornado Body
What Is So Special About Christmas?
Environmental Enigma #001